Back to search

Article

Etrinabdione (VCE-004.8), a B55α activator, promotes angiogenesis and arteriogenesis in critical limb ischemia

2024-04-29

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Vasculogenic therapies explored for the treatment of peripheral artery disease (PAD) have encountered minimal success in clinical trials. Addressing this, B55α, an isoform of protein phosphatase 2A (PP2A), emerges as pivotal in vessel remodeling through activation of hypoxia-inducible factor 1α (HIF-1α). This study delves into the pharmacological profile of VCE-004.8 (Etrina...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
375ff100-64e4-52a8-b432-0bec8cd15a96
DOI
10.1101/2024.04.26.591240
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Etrinabdione (VCE-004.8), a B55α activator, promotes angiogenesis and arteriogenesis in critical limb ischemiaDOI 10.1101/2024.04.26.591240
Select a neighboring publication to make it the new centre.